Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myeloid Leukemia (Relapsed/Refractory)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT00006462
What this trial is testing

Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 32
Testing effectiveness (Phase 2)UnknownNCT06434662
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML

Who this might be right for
Relapsed/Refractory Acute Myeloid LeukaemiaMyeloid Malignancy
First Affiliated Hospital of Zhejiang University 34
Early research (Phase 1)Study completedNCT02675478
What this trial is testing

Phase 1 Study of Quizartinib

Who this might be right for
Relapsed AMLRefractory AML
Daiichi Sankyo Co., Ltd. 17
Testing effectiveness (Phase 2)Looking for participantsNCT06660368
What this trial is testing

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia (AML)
H. Lee Moffitt Cancer Center and Research Institute 52
Early research (Phase 1)Looking for participantsNCT04167696
What this trial is testing

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Celyad Oncology SA 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06052813
What this trial is testing

BN104 in the Treatment of Acute Leukemia

Who this might be right for
ALL, AdultAML, AdultAcute Leukaemia+4 more
Institut de Recherches Internationales Servier (I.R.I.S.) 66
Testing effectiveness (Phase 2)Study completedNCT01743859
What this trial is testing

Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Colorado, Denver 37
Early research (Phase 1)Looking for participantsNCT06994676
What this trial is testing

CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Who this might be right for
High-risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia (CMML)AML - Acute Myeloid Leukemia+1 more
Crossbow Therapeutics, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00809276
What this trial is testing

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Who this might be right for
LymphomaMultiple MyelomaLeukemia+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Early research (Phase 1)Looking for participantsNCT06399640
What this trial is testing

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Who this might be right for
Relapsed Myelodysplastic SyndromeRefractory Myelodysplastic SyndromeAcute Myeloid Leukemia+2 more
Vanderbilt-Ingram Cancer Center 60
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Not applicableLooking for participantsNCT06879847
What this trial is testing

A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Ended earlyNCT06268574
What this trial is testing

Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome
Ryvu Therapeutics SA 62
Early research (Phase 1)Ended earlyNCT03922477
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hoffmann-La Roche 13
Testing effectiveness (Phase 2)Study completedNCT02642965
What this trial is testing

Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Post Cytotoxic TherapyRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia
Children's Oncology Group 38
Early research (Phase 1)Study completedNCT01249430
What this trial is testing

Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00053144
What this trial is testing

Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07722312
What this trial is testing

S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation

Who this might be right for
Relapsed or Refractory Acute LeukemiaRelapsed or Refractory Acute Myeloid Leukemia
Servier 80
Early research (Phase 1)Study completedNCT01385423
What this trial is testing

Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 26
Next Page